Co-Crystals of Active Pharmaceutical Ingredients - Acetazolamide
- 29 June 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 10 (8), 3732-3742
- https://doi.org/10.1021/cg1005693
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Co-Crystallization as a Separation Technology: Controlling Product Concentrations by Co-CrystalsCrystal Growth & Design, 2010
- Pharmaceutical Cocrystals and Their Physicochemical PropertiesCrystal Growth & Design, 2009
- Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: AcetazolamideJournal of Pharmaceutical Sciences, 2008
- Current directions in co-crystal growthNew Journal of Chemistry, 2008
- Applying Hot-Stage Microscopy to Co-Crystal Screening: A Study of Nicotinamide with Seven Active Pharmaceutical IngredientsCrystal Growth & Design, 2008
- Crystallization Pathways and Kinetics of Carbamazepine–Nicotinamide Cocrystals from the Amorphous State by In Situ Thermomicroscopy, Spectroscopy, and Calorimetry StudiesJournal of Pharmaceutical Sciences, 2007
- Over one hundred solvates of sulfathiazoleChemical Communications, 2001
- Structural basis of inhibitor affinity to variants of human carbonic anhydrase IIBiochemistry, 1995
- Drug-Protein InteractionsJournal of Molecular Biology, 1994
- Physico-chemical properties and isothermal transition of acetazolamide polymorphs.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985